{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:40:46Z","timestamp":1761100846070,"version":"3.44.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1053\/j.seminhematol.2006.01.004","type":"journal-article","created":{"date-parts":[[2006,4,6]],"date-time":"2006-04-06T11:42:08Z","timestamp":1144323728000},"page":"107-117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Allogeneic Transplantation for the Elderly Patient With Acute Myelogenous Leukemia or Myelodysplastic Syndrome"],"prefix":"10.1053","volume":"43","author":[{"given":"Marcos","family":"de Lima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Giralt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminhematol.2006.01.004_bib1","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2105\/AJPH.2003.033324","article-title":"Biological basis of determinants of health","volume":"95","author":"Bortz","year":"2005","journal-title":"Am J Public Health"},{"key":"10.1053\/j.seminhematol.2006.01.004_bib2","unstructured":"SEER: Surveillance, Epidemiology and End Results (SEER). SEER CANCER GOV (accessed on August, 2005)"},{"key":"10.1053\/j.seminhematol.2006.01.004_bib3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.critrevonc.2003.04.007","article-title":"Acute myeloid leukemia in the older patient","volume":"48S","author":"Godwin","year":"2003","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1053\/j.seminhematol.2006.01.004_bib4","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1146\/annurev.genom.3.032802.115046","article-title":"Genetics of myeloid leukemias","volume":"3","author":"Kelly","year":"2002","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"10.1053\/j.seminhematol.2006.01.004_bib5","doi-asserted-by":"crossref","first-page":"9194","DOI":"10.1073\/pnas.0503280102","article-title":"Cell intrinsic alterations underlie hematopoietic stem cell aging","volume":"102","author":"Rossi","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminhematol.2006.01.004_bib6","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1182\/asheducation-2001.1.62","article-title":"Acute myeloid leukemia","author":"Appelbaum","year":"2001","journal-title":"Hematology (Am Soc Hematol Educ Program)"},{"key":"10.1053\/j.seminhematol.2006.01.004_bib7","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.1182\/blood.V90.12.4719","article-title":"Implications of potential cure in acute myelogenous leukemia","volume":"90","author":"de Lima","year":"1997","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2006.01.004_bib8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1046\/j.1365-2141.1996.4771012.x","article-title":"Treatment of newly diagnosed acute myelogenous leukemia in-patients age 80 years and above","volume":"93","author":"de Lima","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2006.01.004_bib9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1053\/shem.2002.30909","article-title":"Nonablative stem cell transplantation for older patients with acute leukemias and myelodysplastic syndromes","volume":"39","author":"Giralt","year":"2002","journal-title":"Semin Hematol"},{"key":"10.1053\/j.seminhematol.2006.01.004_bib10","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1182\/blood.V86.5.2041.bloodjournal8652041","article-title":"Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients","volume":"86","author":"Kolb","year":"1995","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2006.01.004_bib11","first-page":"94","article-title":"Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantation. Biology and current indications","volume":"17","author":"Champlin","year":"2003","journal-title":"Oncology (Williston Park)"},{"key":"10.1053\/j.seminhematol.2006.01.004_bib12","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.1200\/JCO.2003.05.501","article-title":"Nonablative allogeneic stem-cell transplantation for advanced\/recurrent mantle-cell lymphoma","volume":"21","author":"Khouri","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminhematol.2006.01.004_bib13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1385\/IR:28:1:13","article-title":"The transplantation of hematopoietic stem cells after non-myeloablative conditioning","volume":"28","author":"Maris","year":"2003","journal-title":"Immunol Res"},{"key":"10.1053\/j.seminhematol.2006.01.004_bib14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.leu.2403594","article-title":"Unrelated donor transplantation over the age of 55. Are we merely getting (b)older?","volume":"19","author":"van Besien","year":"2005","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2006.01.004_bib15","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.bbmt.2003.10.006","article-title":"Acute and chronic graft-versus-host disease after ablative and nonmyeloablative conditioning for allogeneic hematopoietic transplantation","volume":"10","author":"Couriel","year":"2004","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1053\/j.seminhematol.2006.01.004_bib16","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1182\/blood-2004-10-4039","article-title":"Lessened severe graft-versus-host after \u201cminitransplantations\u201d","volume":"105","author":"Sorror","year":"2005","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2006.01.004_bib17","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1182\/blood-2004-02-0545","article-title":"Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning","volume":"104","author":"Sorror","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2006.01.004_bib18","doi-asserted-by":"crossref","first-page":"6690","DOI":"10.1200\/JCO.2005.07.070","article-title":"Effect of age and previous autologous transplantation on nonrelapse mortality and survival in patients treated with reduced-intensity conditioning and allografting for advance hematologic malignancies","volume":"23","author":"Corradini","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminhematol.2006.01.004_bib19","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1200\/JCO.2005.08.136","article-title":"Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning","volume":"23","author":"Baron","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminhematol.2006.01.004_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coi.2005.07.013","article-title":"The aging innate immune system","volume":"17","author":"Gomez","year":"2005","journal-title":"Curr Opin Immunol"},{"key":"10.1053\/j.seminhematol.2006.01.004_bib21","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1126\/science.285.5426.412","article-title":"Prevention of graft versus host disease by inactivation of host antigen-presenting cells","volume":"285","author":"Shlomchik","year":"1999","journal-title":"Science"},{"key":"10.1053\/j.seminhematol.2006.01.004_bib22","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1172\/JCI0214793","article-title":"Enhanced allostimulatory activity of host antigen-presenting cells in old mice intensifies acute graft-versus-host disease","volume":"109","author":"Ordemann","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1053\/j.seminhematol.2006.01.004_bib23","first-page":"1","article-title":"Signal transduction in the aging immune system","volume":"17","author":"Akha","year":"2005","journal-title":"Curr Opin Immunol"},{"key":"10.1053\/j.seminhematol.2006.01.004_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coi.2005.07.020","article-title":"T cell development and receptor diversity during aging","volume":"17","author":"Goronzy","year":"2005","journal-title":"Curr Opin Immunol"},{"key":"10.1053\/j.seminhematol.2006.01.004_bib25","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1182\/blood.V98.7.2043","article-title":"Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors","volume":"98","author":"Kollman","year":"2001","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2006.01.004_bib26","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/sj.bmt.1705041","article-title":"Comorbidity indices in hematopoietic stem cell transplantation","volume":"36","author":"Alamo","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1053\/j.seminhematol.2006.01.004_bib27","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2005-05-2004","article-title":"Hematopoietic cell transplantation-specific comorbidity index","author":"Sorror","year":"2005","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2006.01.004_bib28","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"10.1053\/j.seminhematol.2006.01.004_bib29","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1182\/blood-2004-03-0804","article-title":"Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors","volume":"104","author":"Diaconescu","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2006.01.004_bib30","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1182\/blood-2003-11-3750","article-title":"Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome","volume":"104","author":"de Lima","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2006.01.004_bib31","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1182\/blood.V92.4.1455","article-title":"Long-term follow-up of a randomized trial of two irradiation regimens for patients receiving allogeneic marrow transplants during first remission of acute myeloid leukemia","volume":"92","author":"Clift","year":"1998","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2006.01.004_bib32","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1046\/j.1365-2141.2003.04057.x","article-title":"Non-myeloablative allografting from human leucocyte antigen-identical sibling donors for treatment of acute myeloid leukaemia in first complete remission","volume":"120","author":"Feinstein","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2006.01.004_bib33","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1182\/blood.V94.9.3234","article-title":"Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation","volume":"94","author":"Childs","year":"1999","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2006.01.004_bib34","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood.V91.3.756","article-title":"Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases","volume":"91","author":"Slavin","year":"1998","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2006.01.004_bib35","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1182\/blood.V89.12.4531","article-title":"Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy","volume":"89","author":"Giralt","year":"1997","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2006.01.004_bib36","first-page":"1","article-title":"Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic hematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia","author":"Aoudjane","year":"2005","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2006.01.004_bib37","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1182\/blood-2004-05-1947","article-title":"Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic stem cell transplantation for patients older than 50 years of age","volume":"105","author":"Alyea","year":"2005","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2006.01.004_bib38","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1200\/JCO.2005.05.694","article-title":"Ablative allogeneic hematopoietic cell transplantation in adults 60 years of age and older","volume":"23","author":"Wallen","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminhematol.2006.01.004_bib39","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1182\/blood-2004-02-0414","article-title":"Once-daily intravenous busulfan and fludarabine","volume":"104","author":"de Lima","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2006.01.004_bib40","first-page":"10","article-title":"Treatment of AML\/MDS with allogeneic hematopoietic stem cell transplantation after intravenous busulfan-based conditioning therapy","volume":"15","author":"de Lima","year":"2005","journal-title":"Biol Blood Marrow Transplant Rev"},{"key":"10.1053\/j.seminhematol.2006.01.004_bib41","doi-asserted-by":"crossref","first-page":"660a","DOI":"10.1182\/blood.V106.11.660.660","article-title":"Outcomes of older patients with myeloid leukemias treated with myeloablative intravenous busulfan-based conditioning regimens and allogeneic blood or marrow transplantation","volume":"106","author":"de Lima","year":"2005","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2006.01.004_bib42","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/sj.leu.2403591","article-title":"Hematopoietic stem-cell transplantation from unrelated donors in elderly patients (age >55 years) with hematologic malignancies","volume":"19","author":"Shimoni","year":"2005","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2006.01.004_bib43","first-page":"8","article-title":"Myeloablative conditioning using IV busulfan reduces toxicity to the level observed in low-intensity conditioning regimens","volume":"15","author":"Nagler","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1053\/j.seminhematol.2006.01.004_bib44","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1182\/blood-2004-01-0338","article-title":"A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes","volume":"104","author":"Cutler","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2006.01.004_bib45","first-page":"542","article-title":"The Thompson\/Luger article reviewed","volume":"19","author":"Estey","year":"2005","journal-title":"Oncology"},{"key":"10.1053\/j.seminhematol.2006.01.004_bib46","doi-asserted-by":"crossref","first-page":"2892a","DOI":"10.1182\/blood.V106.11.2892.2892","article-title":"Prospective feasibility analysis of reduced intensity conditioning regimens (RIC) for hematopoietic stem cell transplantation (HSCT) in elderly patients with AML and MDS","volume":"106","author":"Tibes","year":"2005","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2006.01.004_bib47","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.bbmt.2004.10.001","article-title":"Pretransplantation induction chemotherapy and posttransplantation relapse in patients with advanced myelodysplastic syndrome","volume":"11","author":"Scott","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1053\/j.seminhematol.2006.01.004_bib48","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1182\/blood-2004-11-4282","article-title":"Effects of aging on the homing and engraftment of murine hematopoietic stem and progenitor cells","volume":"106","author":"Liang","year":"2005","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2006.01.004_bib49","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1146\/annurev.med.56.082103.104546","article-title":"DNA repair defects in stem cell function and aging","volume":"56","author":"Park","year":"2005","journal-title":"Annu Rev Med"},{"key":"10.1053\/j.seminhematol.2006.01.004_bib50","doi-asserted-by":"crossref","first-page":"2916a","DOI":"10.1182\/blood.V106.11.2916.2916","article-title":"Influence of allele level HLA typing on unrelated donor (UD) transplantation for high-risk myeloid leukemias","volume":"106","author":"Parmar","year":"2005","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2006.01.004_bib51","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1182\/blood.V99.3.1071","article-title":"Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen","volume":"99","author":"Chakraverty","year":"2002","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2006.01.004_bib52","doi-asserted-by":"crossref","first-page":"5728","DOI":"10.1200\/JCO.2005.15.602","article-title":"Fludarabine, melphalan, and alemtuzumab conditioning in adults with standard-risk advanced acute myeloid leukemia and myelodysplastic syndrome","volume":"23","author":"van Besien","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminhematol.2006.01.004_bib53","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1182\/blood-2003-12-4207","article-title":"Reduced-intensity allogeneic hematopoietic stem cell transplantion for myelodysplastic syndrome and acute myeloid leukemia with multilineage dysplasia using fludarabine, busulfan and alemtuzumab (FBC) conditioning","volume":"104","author":"Ho","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2006.01.004_bib54","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.bbmt.2005.03.003","article-title":"Reduced-intensity conditioning allogeneic blood stem cell transplantation with fludarabine and oral busulfan with or without pharmacokinetically targeted busulfan dosing in patients with myeloid leukemia ineligible for conventional conditioning","volume":"11","author":"Martino","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1053\/j.seminhematol.2006.01.004_bib55","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1182\/blood-2003-02-0482","article-title":"HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies","volume":"102","author":"Maris","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2006.01.004_bib56","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1200\/JCO.2003.09.110","article-title":"Allogeneic stem-cell transplantation from related and unrelated donors in older patients with myeloid leukemia","volume":"21","author":"Bertz","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminhematol.2006.01.004_bib57","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1200\/JCO.2005.05.694","article-title":"Ablative allogeneic hematopoietic cell transplantation in adults 60 years of age and older","volume":"23","author":"Wallen","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminhematol.2006.01.004_bib58","doi-asserted-by":"crossref","first-page":"4147","DOI":"10.1182\/blood-2005-01-0196","article-title":"Hematopoietic cell transplantation from unrelated donors as an effective therapy for older patients (>= 60 years) with active myeloid malignancies (letter)","volume":"105","author":"Spyridonidis","year":"2005","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2006.01.004_bib59","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1182\/blood-2003-03-0855","article-title":"Reduced-intensity conditioning for unrelated donor hematopoietic stem cell transplantation as treatment for myeloid malignancies in patients older than 55 years","volume":"102","author":"Wong","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2006.01.004_bib60","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.1200\/JCO.2005.07.061","article-title":"Sequential regimen of chemotherapy, reduced-intensity conditioning for allogeneic stem-cell transplantation, and prophylactic donor-lymphocyte transfusion in high-risk acute myeloid leukemia and myelodysplastic syndrome","volume":"23","author":"Schmid","year":"2005","journal-title":"J Clin Oncol"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196306000217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196306000217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T06:16:56Z","timestamp":1758521816000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196306000217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S0037196306000217"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2006.01.004","relation":{},"ISSN":["0037-1963"],"issn-type":[{"type":"print","value":"0037-1963"}],"subject":[],"published":{"date-parts":[[2006,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Allogeneic Transplantation for the Elderly Patient With Acute Myelogenous Leukemia or Myelodysplastic Syndrome","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2006.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}